Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan, James Brett Case, Emma S. Winkler, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 744-753.e4
Open Access | Times Cited: 538

Showing 26-50 of 538 citing articles:

Multi-organ proteomic landscape of COVID-19 autopsies
Xiu Nie, Liujia Qian, Rui Sun, et al.
Cell (2021) Vol. 184, Iss. 3, pp. 775-791.e14
Open Access | Times Cited: 357
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1804-1820.e16
Open Access | Times Cited: 349
Lessons for COVID-19 Immunity from Other Coronavirus Infections
Alan Sariol, Stanley Perlman
Immunity (2020) Vol. 53, Iss. 2, pp. 248-263
Open Access | Times Cited: 332
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin, et al.
Immunity (2020) Vol. 53, Iss. 4, pp. 724-732.e7
Open Access | Times Cited: 327
Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang, Paul Bastard, Adem Karbuz, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 587-598
Open Access | Times Cited: 315
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 297
Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
Meng Guo, Wanyin Tao, Richard A. Flavell, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 4, pp. 269-283
Open Access | Times Cited: 294
The aging lung: Physiology, disease, and immunity
Jaime L. Schneider, Jared H. Rowe, Carolina García de Alba, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 1990-2019
Open Access | Times Cited: 293
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009195-e1009195
Open Access | Times Cited: 292
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Dapeng Li, Robert J. Edwards, Kartik Manne, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4203-4219.e32
Open Access | Times Cited: 277
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 273
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Ioannis P. Trougakos, Κimon Stamatelopoulos, Evangelos Terpos, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 240
The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection
Oreste Gallo, Luca Giovanni Locatello, Alessio Mazzoni, et al.
Mucosal Immunology (2020) Vol. 14, Iss. 2, pp. 305-316
Open Access | Times Cited: 238
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
Kyle Rosenke, Kimberly Meade‐White, Michael Letko, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2673-2684
Open Access | Times Cited: 230
Comparison of nonhuman primates identified the suitable model for COVID-19
Shuaiyao Lu, Yuan Zhao, Wenhai Yu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 224
Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2
Yinghui Liu, Gaowei Hu, Yuyan Wang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 12
Open Access | Times Cited: 218
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W. Golden, Curtis R. Cline, Xiankun Zeng, et al.
JCI Insight (2020) Vol. 5, Iss. 19
Open Access | Times Cited: 217
SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells
Antoine Rebendenne, Ana Luiza Chaves Valadão, Marine Tauziet, et al.
Journal of Virology (2021) Vol. 95, Iss. 8
Open Access | Times Cited: 214
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Wafaa B. Alsoussi, Jackson S. Turner, James Brett Case, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 4, pp. 915-922
Open Access | Times Cited: 209
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression
Günther Schönrich, Martin Raftery, Yvonne Samstag
Advances in Biological Regulation (2020) Vol. 77, pp. 100741-100741
Open Access | Times Cited: 204
Structural basis for broad coronavirus neutralization
Maximilian M. Sauer, M. Alejandra Tortorici, Young‐Jun Park, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 6, pp. 478-486
Open Access | Times Cited: 195
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S. Ladinsky, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2143-2158.e15
Open Access | Times Cited: 193
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2433-2445
Open Access | Times Cited: 192
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
Natalia Sherina, Antonio Piralla, Likun Du, et al.
Med (2021) Vol. 2, Iss. 3, pp. 281-295.e4
Open Access | Times Cited: 192

Scroll to top